Collector
OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios) | Collector
OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios)
Techmeme

OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios)

Megan Morrone / Axios : OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen —  OpenAI announced a new series of AI models built to help life sciences researchers work faster.

Go to News Site